James Investment Research’s Magellan Health Services, Inc. MGLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-21
Closed -$2K – 553
2019
Q4
$2K Sell
21
-32
-60% -$2.25K ﹤0.01% 499
2019
Q3
$3K Hold
53
– – ﹤0.01% 549
2019
Q2
$4K Hold
53
– – ﹤0.01% 632
2019
Q1
$3K Sell
53
-14,740
-100% -$946K ﹤0.01% 794
2018
Q4
$842K Buy
14,793
+8,515
+136% +$525K 0.05% 419
2018
Q3
$453K Sell
6,278
-6,390
-50% -$514K 0.02% 521
2018
Q2
$1.22M Sell
12,668
-19,819
-61% -$1.9M 0.05% 461
2018
Q1
$3.48M Sell
32,487
-2,142
-6% -$215K 0.13% 151
2017
Q4
$3.34M Buy
+34,629
New +$3.06M 0.11% 143
2017
Q2
– Sell
-24,427
Closed -$1.69M – 790
2017
Q1
$1.69M Buy
+24,427
New +$1.78M 0.05% 265

Other funds holding MGLN

James Investment Research's MGLN Position: Q1 2020 in Review

James Investment Research sold out of Magellan Health Services, Inc. (MGLN) in Q1 2020, closing a stake of 21 shares — an estimated $2K sold.

James Investment Research first reported a position in MGLN in Q1 2017 and held it in 10 quarters. The position peaked at $3.48M in Q1 2018. 167 funds tracked by Wall St. Rank hold MGLN as of Q1 2020.

  • James Investment Research reported no remaining Magellan Health Services, Inc. position as of Q1 2020 after selling out during the quarter.
  • James Investment Research sold 21 Magellan Health Services, Inc. shares in Q1 2020, an estimated $2K.
  • James Investment Research first reported a position in Magellan Health Services, Inc. in Q1 2017 and held it in 10 quarters.
  • James Investment Research's Magellan Health Services, Inc. position peaked at $3.48M in Q1 2018.
  • 167 funds tracked by Wall St. Rank held Magellan Health Services, Inc. as of Q1 2020.

Based on James Investment Research's 13F filing for Q1 2020, filed 22 Apr 2020.